Cresco Labs (XCNQ:CL) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs 3-Year EBITDA Growth Rate?

Cresco Labs's EBITDA per Share for the three months ended in Dec. 2023 was C$0.20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cresco Labs was 46.90% per year. The lowest was -55.40% per year. And the median was 18.60% per year.

Competitive Comparison of Cresco Labs's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cresco Labs's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cresco Labs's 3-Year EBITDA Growth Rate falls into.

Cresco Labs 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cresco Labs (XCNQ:CL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cresco Labs 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cresco Labs's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs (XCNQ:CL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CRLBF:USA 6CQ:Germany

Address

400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654

Website

https://www.crescolabs.com

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.